Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
October 16, 2024
Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
September 30, 2024
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 30, 2024
Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference
September 30, 2024
Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
September 19, 2024
ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
August 30, 2024
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 27, 2024
Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 19, 2024
Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
August 13, 2024
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 1, 2024
Adicet Bio to Participate in Upcoming Investor Conferences

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page next ›
  • Last page last »
Displaying 11 - 20 of 44

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2024 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.